drugset / Trial / NCT00011362

Dexamethasone Therapy in VLBW Infants at Risk of CLD

NCT00011362 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Infants who are on breathing support are often treated with steroids (dexamethasone); however, the best timing of therapy is not known. This trial looked at the benefits and hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in premature infants.

Timeline

Start
1992-09
Primary completion
1994-01
Completion
1994-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 0.25 mg/kg Intravenous